In February 2026, a study was released that stated that statin drugs didn’t cause most of the side effects attributed to them and that the statin pack inserts (patient advice) should be modified to reflect this. This raises these questions: which side effects were studied – and are they the real side effects of taking statins?
Main Points
- Two side effects – muscle damage and diabetes – were excluded from the 2026 study;
- These two side effects are the most common and most serious;
- All side effects were split into 66 subgroups, making meaningful comparison difficult;
- An independent analysis of the study reveals more that the study did.
Last reviewed May 2026.
(If you’d like to explore independent perspectives on preventing heart disease — including approaches beyond statins — you may also find our plain-English guide, Heart Disease: Take Back Control, useful.)
What Side Effects Did The Study Find?
The 2026 study concluded that only four out of 66 side effects impacted patients- and that impact was minor. That certainly sounds very positive but surely the number 66 for side effects must raise some questions?
This is what the study actually said:
These findings indicate that, in addition to the previously reported adverse effects of statin therapy on muscle outcomes and diabetes, statins are associated only with small absolute increases in abnormal liver biochemistry, and possible adverse effects of unknown clinical relevance on urinary composition and oedema, but not with any other outcomes listed in statin SmPCs. (Summary of Product Characteristics) – what we call ‘pack inserts’ in Australia.
In other words, diabetes and muscle damage were excluded and the other side effects were insignificant.
That might be surprising. In other words, if the real side effects of statins were insignificant, why was this study necessary?

What Real Side effects of Taking Statins Were Missed?
There are two problems here. Firstly, that the most serious and common side effects are these two: diabetes (Type 2 not Type 1) and muscle damage.
These were excluded because, as the authors put it, this 2026 statin side effects study was ‘in addition to the previously reported adverse effects of statin therapy on muscle outcomes and diabetes‘. In other words, they had dealt with them elsewhere and muscle damage was ‘muscle outcomes’, anyway. Not serious, we might infer.
Even in the industry-sponsored 2008 JUPITER trial of Crestor (Rosuvastatin from AstraZeneca), diabetes was noted. (JUPITER is the landmark trial that established that stains could prevent, not just treat, heart disease). In JUPITER, diabetes was 26% higher in the drug group compared to placebo.
In other trials, diabetes was 30-50% higher in women who took statins compared to those who didn’t. You can read about these trials and JUPITER here.
Diabetes matters, especially for women.
It’s the number one risk factor for heart disease, according to the 21-year followup of the Women’s Health Study running since 1993. That is, LDL-C (‘bad’ cholesterol) doesn’t rank in the top six risk factors and ranks at five out of six for biochemical markers (see at right).
In other words, taking a statin may reduce ‘bad cholesterol’, but may increase risk of heart disease by causing diabetes, especially for women. That’s a real side effect of taking statins.
Not Uncommon Either
Muscle damage isn’t rare either, and it’s more serious than ‘muscle outcomes’ might suggest.

Muscle stiffness, weakness, cramping and muscle loss (see the highlighted quote below) affect about 10% of statin takers, according to the NNT (a site which also analyses clinical trial data, but just the numbers). NNT is the ‘Number Needed to Treat’ before one patient gains a benefit. For statins, that number is 104 for a non-fatal heart attack. Conversely, the NNH – ‘Number Needed to Harm’ – for statins is 10 for muscle damage and 50 for diabetes.
According to these numbers, at least twice as patients are harmed than helped by statins. (You can read more on what these figures mean here).
Australian cardiologist, Ross Walker, is not a statin sceptic. He prescribes statins but only to very specific patients. From his experience, he says the side effect number is twice as high at 20%. He also maintains, that of the 19 million statin prescriptions written for Australians each year, 18 million of them should not be. That’s because, in his opinion, they benefit very few and should not be taken for primary prevention.
20% of people taking statins will experience a degree of muscle pain, stiffness, weakness, cramping and even a loss of muscle bulk, known as atrophy. 20% of people taking statins will experience problems with memory, concentration, depression, fatigue, irritability and poor sleep. There is, at times, an effect on liver function and in very rare cases this may be quite serious. There is a potential increase risk for diabetes in people who are insulin resistant. There are a number of non-specific side-effects that are common to many drugs such as headache, skin rash and constipation, to name a few.
Ross Walker, Australian cardiologist
In summary, real side effects of taking statins are not uncommon – they affect 10-20% of patients – and include muscle damage, brain fog, mood changes, poor sleep and diabetes. If you read only the 2026 study, you certainly would not conclude that. If you read only the press release, you’d think that statins are harmless.
Not Statistically Significant
That’s not the only problem with the statin side effects reported in the 2026 study.
The fact there was 66 reported is of huge concern, not because they were all significant but because they were not. The authors broke each side effect – such ‘muscular weakness, weakness or pain’ – into multiple biochemical measurements, making it virtually impossible to know which contributed to what side effect and which, if any, was severe. For that, we rely upon the study authors.
Also, by breaking each one into biochemical components, each one became too small to be statistically significance. Is this a coincidence?
Table 4 above right is from the JUPITER 2008 Clinical Trial, where only 11 ‘adverse effects’ were noted, each one as a symptom, not a biochemical measurement. Recall that this was the trial which established statins as a heart disease preventative for healthy people, so it had reason to minimise not maximise side effects, yet there they are for all to see.
In a nutshell, it appears that statins do have side effects, some are common, some are serious and some are both. If you read the 2026 study in isolation you might conclude the exact opposite, as the authors did.
***
If you’re curious about the shenanigans of drug companies and their clinical trials and would like a more objective, independent perspective, you may like to see what’s inside our eBook, Heart Disease: Take Back Control.
HEART DISEASE:
TAKE BACK CONTROL
How you can get off the ‘cardiac conveyor belt’ & thrive
Related Blog Posts
How Serious Are Statin Side Effects? What New Research Shows – the full independent analysis of the ‘2026 Statin Side Effects Study’
Statins: A History of Deception? (Analysis)? (blog post) – the full history of statin medication research;
Sons of Statin: The Deception Continues (blog post) – the new generation of cholesterol-lowering drugs;
How Independent Is The CTT Collaboration? (blog post) – a look at funding and independence;
Who Are The Authors of the ‘2026 Statin Side Effects Study’? (blog post) – the name on the review isn’t the name of the authors;
How Objective Was The ‘2026 Statin Side Effects Study’? (blog post) – analysis by independent researchers;
***



